JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sadrzadeh, S. M.
Right arrow Articles by Price, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sadrzadeh, S. M.
Right arrow Articles by Price, P. L.

The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats

SM Sadrzadeh, AA Nanji and PL Price

Department of Pathology, New England Deaconess Hospital, Boston, MA 02215.

The effect of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) on liver nonheme iron, lipid peroxidation and hepatic fat accumulation in the intragastric feeding rat model for alcoholic liver disease was studied. Male Wistar rats (225-250 g) were fed liquid diet and ethanol for 1 month. In control pair-fed animals, ethanol was replaced isocalorically by dextrose. Two additional groups of animals (dextrose and ethanol-fed) received L1 (75 mg/kg/day for 30 days). The blood ethanol level in the ethanol-fed animals was maintained between 150 and 350 mg/dl. For each animal, the levels of hepatic nonheme iron, lipid peroxidation and triglyceride were evaluated. The nonheme iron in alcohol-fed animals was significantly higher (416 +/- 15 nmol/g of liver) than in pair-fed dextrose controls (346 +/- 18.5 nmol/g, P < .05). Animals fed ethanol and L1 had significantly lower nonheme iron (364 +/- 9.3 nmol/g) than rats fed ethanol alone (P < .05). L1 had no effect on nonheme iron levels in dextrose-fed controls. The importance of iron in lipid peroxidation in this model is shown by the positive correlation between the nonheme iron levels and microsomal conjugated dienes (r = 0.67, P < .02) and liver thiobarbituric acid reactive substances (r = 0.62, P < .05). The most significant observations in this study were: 1) the higher hepatic nonheme iron content in ethanol- fed rats compared to pair-fed dextrose controls; 2) lower nonheme iron and liver fat in the ethanol-fed rats treated with L1; and 3) the significant positive correlation between the liver nonheme and lipid peroxidation.

Volume 269, Issue 2, pp. 632-636, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Xiong, H. She, A.-S. Zhang, J. Wang, H. Mkrtchyan, A. Dynnyk, V. R. Gordeuk, S. W. French, C. A. Enns, and H. Tsukamoto
Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis
Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G512 - G521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bai and A. I. Cederbaum
Overexpression of CYP2E1 in Mitochondria Sensitizes HepG2 Cells to the Toxicity Caused by Depletion of Glutathione
J. Biol. Chem., February 24, 2006; 281(8): 5128 - 5136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. She, S. Xiong, M. Lin, E. Zandi, C. Giulivi, and H. Tsukamoto
Iron activates NF-kappa B in Kupffer cells
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G719 - G726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. A. Nanji, K. Jokelainen, M. Fotouhinia, A. Rahemtulla, P. Thomas, G. L. Tipoe, G. L. Su, and A. J. Dannenberg
Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines
Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1348 - G1356.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. A. Caro and A. I. Cederbaum
Synergistic Toxicity of Iron and Arachidonic Acid in HepG2 Cells Overexpressing CYP2E1
Mol. Pharmacol., October 1, 2001; 60(4): 742 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. H. Sadrzadeh and A. A. Nanji
The 21-Aminosteroid 16-Desmethyl Tirilazad Mesylate Prevents Necroinflammatory Changes in Experimental Alcoholic Liver Disease
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 406 - 412.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. H. Sadrzadeh, P. E. Hallaway, and A. A. Nanji
The Long-Acting Parenteral Iron Chelator, Hydroxyethyl Starch-Deferoxamine, Fails to Protect against Alcohol-Induced Liver Injury in Rats
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1038 - 1042.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Wu and A. I. Cederbaum
Ethanol Cytotoxicity to a Transfected HepG2 Cell Line Expressing Human Cytochrome P4502E1
J. Biol. Chem., September 27, 1996; 271(39): 23914 - 23919.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.